• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过脂质体递送2'-O-甲基RNA对人非小细胞肺癌细胞进行有效的端粒酶抑制

Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.

作者信息

Beisner Julia, Dong Meng, Taetz Sebastian, Piotrowska Kamilla, Kleideiter Elke, Friedel Godehard, Schaefer Ulrich, Lehr Claus-Michael, Klotz Ulrich, Mürdter Thomas E

机构信息

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Germany.

出版信息

J Pharm Sci. 2009 May;98(5):1765-74. doi: 10.1002/jps.21553.

DOI:10.1002/jps.21553
PMID:18803262
Abstract

The antisense oligonucleotide 2'-O-methyl-RNA is a selective telomerase inhibitor targeting the telomerase RNA component and represents a potential candidate for anticancer therapy. The poor cellular uptake of 2'-O-methyl-RNA is a limiting factor that may contribute to the lack of functional efficacy. To improve delivery of 2'-O-methyl-RNA and consequently antitumoral efficiency in human lung cancer cells, we have investigated several transfection reagents. The transfection reagents DOTAP, MegaFectin 60, SuperFect, FuGENE 6 and MATra-A were tested for intracellular delivery. A FAM-labeled 2'-O-methyl-RNA was used to assess the intracellular distribution by confocal laser scanning microscopy in A549 human non-small cell lung cancer cells. Telomerase activity was measured using the telomeric repeat amplification protocol. Cell viability after transfection was quantified by the MTT assay. All transfection reagents enhanced 2'-O-methyl-RNA uptake in A549 cells but the cationic lipid reagents DOTAP and MegaFectin 60 were most efficient in the delivery of 2'-O-methyl-RNA resulting in telomerase inhibition. Among both DOTAP exhibited the lowest cytotoxicity. Our experiments show that DOTAP is the most suitable transfection reagent for the delivery of 2'-O-methyl-RNA in human lung cancer cells according to its relatively low cytotoxicity and its ability to promote efficient uptake leading to the inhibition of telomerase.

摘要

反义寡核苷酸2'-O-甲基核糖核酸是一种靶向端粒酶RNA成分的选择性端粒酶抑制剂,是抗癌治疗的潜在候选药物。2'-O-甲基核糖核酸较差的细胞摄取率是一个限制因素,可能导致功能疗效的缺乏。为了改善2'-O-甲基核糖核酸的递送并因此提高其在人肺癌细胞中的抗肿瘤效率,我们研究了几种转染试剂。测试了转染试剂DOTAP、MegaFectin 60、SuperFect、FuGENE 6和MATra-A的细胞内递送情况。使用FAM标记的2'-O-甲基核糖核酸通过共聚焦激光扫描显微镜评估A549人非小细胞肺癌细胞中的细胞内分布。使用端粒重复序列扩增协议测量端粒酶活性。通过MTT法对转染后的细胞活力进行定量。所有转染试剂均增强了A549细胞对2'-O-甲基核糖核酸的摄取,但阳离子脂质试剂DOTAP和MegaFectin 60在递送2'-O-甲基核糖核酸方面最有效,从而导致端粒酶抑制。在这两种试剂中,DOTAP表现出最低的细胞毒性。我们的实验表明,根据其相对较低的细胞毒性以及促进有效摄取从而抑制端粒酶的能力,DOTAP是在人肺癌细胞中递送2'-O-甲基核糖核酸最合适的转染试剂。

相似文献

1
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.通过脂质体递送2'-O-甲基RNA对人非小细胞肺癌细胞进行有效的端粒酶抑制
J Pharm Sci. 2009 May;98(5):1765-74. doi: 10.1002/jps.21553.
2
Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.纳米颗粒介导的 2'-O-甲基-RNA 递送至人肺癌细胞中可有效抑制端粒酶并缩短端粒。
Lung Cancer. 2010 Jun;68(3):346-54. doi: 10.1016/j.lungcan.2009.07.010. Epub 2009 Aug 19.
3
Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.用于将抗端粒酶小干扰RNA靶向递送至表达CD44的肺癌细胞的透明质酸修饰的DOTAP/DOPE脂质体
Oligonucleotides. 2009 Jun;19(2):103-16. doi: 10.1089/oli.2008.0168.
4
Treatment of lung cancer via telomerase inhibition: self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-Methyl-RNA.通过端粒酶抑制治疗肺癌:自组装纳米复合物与聚合物纳米粒作为 2'-O-甲基-RNA 的载体。
Eur J Pharm Biopharm. 2012 Apr;80(3):478-89. doi: 10.1016/j.ejpb.2011.11.019. Epub 2011 Dec 17.
5
Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.人肺癌组织切片模型研究纳米颗粒传递反义 2'-O-甲基-RNA 对端粒酶的抑制作用。
Int J Pharm. 2011 Oct 31;419(1-2):33-42. doi: 10.1016/j.ijpharm.2011.07.009. Epub 2011 Jul 18.
6
Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.用转染试剂FuGENE6包裹的硫代磷酸反义寡核苷酸对HeLa细胞中人端粒酶活性的抑制作用。
Antisense Nucleic Acid Drug Dev. 2000 Apr;10(2):87-96. doi: 10.1089/oli.1.2000.10.87.
7
Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick?磷酸二酯寡核苷酸的递送:DOTAP/DOPE脂质体能奏效吗?
Biochemistry. 2006 Feb 14;45(6):1755-64. doi: 10.1021/bi0519755.
8
Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.siRNA、反义寡核苷酸和抗癌药物的气管内与静脉内脂质体递送
Pharm Res. 2009 Feb;26(2):382-94. doi: 10.1007/s11095-008-9755-4. Epub 2008 Oct 29.
9
Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification.评价阳离子树状高分子和脂质作为转染试剂对干细胞修饰的短 RNA 效果。
Int J Pharm. 2013 May 1;448(1):231-8. doi: 10.1016/j.ijpharm.2013.03.035. Epub 2013 Mar 25.
10
[Comparison of two kinds of cationic vectors-mediated gene delivery].两种阳离子载体介导的基因递送的比较
Yao Xue Xue Bao. 2009 May;44(5):553-7.

引用本文的文献

1
Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy.肺癌患者血液来源外泌体hTERT mRNA:特征及其与治疗反应的相关性
Biomedicines. 2023 Jun 16;11(6):1730. doi: 10.3390/biomedicines11061730.
2
Delivery of oligonucleotides with lipid nanoparticles.用脂质纳米颗粒递送寡核苷酸。
Adv Drug Deliv Rev. 2015 Jun 29;87:68-80. doi: 10.1016/j.addr.2015.02.007. Epub 2015 Feb 27.